City

Arnhem (1)

Shanghai (1)

Condition

Phosphodiesterase Inhibitor (2)

Alcohol (1)

COPD Exacerbation (1)

Enoximone (1)

Erectile Dysfunction (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 4 (1)

Sponsor

Rijnstate Hospital (1)

Vigonvita Life Sciences (1)

Collaborator

Intervention

alcohol (1)

enoximone (1)

tpn171h tablet (1)

tpn171h tablet plus alcohol (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

phosphodiesterase inhibitor

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction Trial in Shanghai (TPN171H tablet plus alcohol, alcohol, TPN171H

Completed

Alcohol
+2 more

TPN171H tablet plus alcohol
+2 more

Shanghai, China

Shanghai Xuhui Central Hospital

May 20, 2022

COPD Exacerbation, Enoximone, Phosphodiesterase Inhibitor Trial in Arnhem (Enoximone)

Terminated

COPD Exacerbation
+2 more

Enoximone

Arnhem, M, Netherlands

M.V. Koning

Dec 23, 2021